Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 155.00
-1.21 (-0.77%)
Aug 14, 2025, 11:26 AM IST
Brooks Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 902.84 | 825.57 | 794.86 | 632.05 | 911.85 | 772.47 | Upgrade | |
Revenue Growth (YoY) | 10.48% | 3.86% | 25.76% | -30.69% | 18.04% | 10.85% | Upgrade |
Cost of Revenue | 576.6 | 540.73 | 569.73 | 524.09 | 639.79 | 485.69 | Upgrade |
Gross Profit | 326.24 | 284.84 | 225.13 | 107.95 | 272.06 | 286.78 | Upgrade |
Selling, General & Admin | 135.57 | 129.6 | 107.94 | 176.94 | 194.68 | 146.43 | Upgrade |
Other Operating Expenses | 111.34 | 105.85 | 78.51 | 194.77 | 217.67 | 134.57 | Upgrade |
Operating Expenses | 262.83 | 251.46 | 204.19 | 441.97 | 485.86 | 352.44 | Upgrade |
Operating Income | 63.4 | 33.37 | 20.94 | -334.02 | -213.8 | -65.66 | Upgrade |
Interest Expense | -11.68 | -10.28 | -7.25 | -19.54 | -28.31 | -30.98 | Upgrade |
Interest & Investment Income | - | - | 1.07 | 1.27 | 0.91 | 1.85 | Upgrade |
Earnings From Equity Investments | -38.49 | -129.84 | -211.21 | -33.1 | - | -0.08 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 1.53 | -0.43 | 2.22 | - | Upgrade |
Other Non Operating Income (Expenses) | 8.83 | 8.83 | -1.2 | -1.53 | -1.31 | 5.51 | Upgrade |
EBT Excluding Unusual Items | 22.07 | -97.92 | -196.11 | -387.35 | -240.29 | -89.37 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 0.08 | 0.08 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 1.31 | -0.56 | Upgrade |
Other Unusual Items | - | - | 0.37 | 3.57 | - | - | Upgrade |
Pretax Income | 22.07 | -97.92 | -195.66 | -383.7 | -238.98 | -89.93 | Upgrade |
Income Tax Expense | 1.75 | 1.75 | 0.26 | -73.24 | -45.85 | 103.82 | Upgrade |
Earnings From Continuing Operations | 20.31 | -99.67 | -195.92 | -310.46 | -193.13 | -193.76 | Upgrade |
Minority Interest in Earnings | - | - | - | 101.54 | 80.23 | - | Upgrade |
Net Income | 20.31 | -99.67 | -195.92 | -208.92 | -112.9 | -193.76 | Upgrade |
Net Income to Common | 20.31 | -99.67 | -195.92 | -208.92 | -112.9 | -193.76 | Upgrade |
Shares Outstanding (Basic) | 28 | 27 | 26 | 25 | 25 | 25 | Upgrade |
Shares Outstanding (Diluted) | 28 | 27 | 26 | 25 | 25 | 25 | Upgrade |
Shares Change (YoY) | 7.60% | 4.59% | 3.70% | - | - | 40.27% | Upgrade |
EPS (Basic) | 0.73 | -3.72 | -7.65 | -8.46 | -4.57 | -7.84 | Upgrade |
EPS (Diluted) | 0.73 | -3.72 | -7.65 | -8.46 | -4.57 | -7.84 | Upgrade |
Free Cash Flow | - | 15.98 | -101.2 | -149.58 | -650.53 | -11.55 | Upgrade |
Free Cash Flow Per Share | - | 0.60 | -3.95 | -6.05 | -26.33 | -0.47 | Upgrade |
Gross Margin | 36.13% | 34.50% | 28.32% | 17.08% | 29.84% | 37.13% | Upgrade |
Operating Margin | 7.02% | 4.04% | 2.63% | -52.85% | -23.45% | -8.50% | Upgrade |
Profit Margin | 2.25% | -12.07% | -24.65% | -33.05% | -12.38% | -25.08% | Upgrade |
Free Cash Flow Margin | - | 1.93% | -12.73% | -23.67% | -71.34% | -1.49% | Upgrade |
EBITDA | 79.71 | 49.39 | 35.77 | -267.44 | -143.15 | 3.15 | Upgrade |
EBITDA Margin | 8.83% | 5.98% | 4.50% | -42.31% | -15.70% | 0.41% | Upgrade |
D&A For EBITDA | 16.31 | 16.02 | 14.83 | 66.58 | 70.65 | 68.82 | Upgrade |
EBIT | 63.4 | 33.37 | 20.94 | -334.02 | -213.8 | -65.66 | Upgrade |
EBIT Margin | 7.02% | 4.04% | 2.63% | -52.85% | -23.45% | -8.50% | Upgrade |
Effective Tax Rate | 7.95% | - | - | - | - | - | Upgrade |
Revenue as Reported | 911.67 | 834.4 | 804.42 | 634.16 | 919.86 | 779.82 | Upgrade |
Advertising Expenses | - | - | 2.45 | 3.43 | 2.6 | 2.57 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.